Chinese herbal formula for mild to moderate psoriasis
Part of Skin clinical trials.
This trial tests an herbal formula called Shuiniujiao Dihuang Decoction for people with mild to moderate plaque psoriasis. It may help reduce psoriasis symptoms without using stronger medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild to moderate plaque psoriasis with a PASI score between 3 and 12.
- You have not used systemic psoriasis treatments (like pills or injections) in the last 6 months.
- You have not used topical psoriasis treatments (like creams or ointments) in the last 14 days.
- You have not taken antibiotics, probiotics, or prebiotics in the last 30 days.
- You have not had UV light therapy for psoriasis in the last 30 days.
- You are not pregnant, breastfeeding, or planning to become pregnant in the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cream called diacerein for mild plaque psoriasis. If you have small patches of psoriasis and haven't used other treatments recently, this cream might help reduce redness and scaling.
This study tests a new injection called SHR-1139 for people with moderate-to-severe plaque psoriasis. The goal is to see if it can safely improve your skin condition.
This trial tests a traditional Chinese herbal formula (Modified Qing-Ying Decoction) for children ages 4 to 17 with moderate-to-severe eczema (atopic dermatitis). The study aims to see if this herbal treatment can improve skin dryness, redness, and itching, especially for those with dry, scaly patches.
This trial tests a Chinese herbal pill for people with mild-to-moderate plaque psoriasis. The pill is meant to reduce redness, scaling, and inflammation by targeting a specific pattern in traditional Chinese medicine.
This trial tests a new medication called HSK44459 for people with moderate to severe plaque psoriasis who need systemic therapy (medicine that works throughout the body). The goal is to see if it is safe and effective.
This trial tests an oral tablet (CMS-D001) for adults with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing psoriasis severity.
Hear when a new Psoriasis Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.